NCT07602374 Efficacy of Written Versus Video Patient Education Materials for Postmastectomy Breast Reconstruction
| NCT ID | NCT07602374 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Breast Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-06-06 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-06-06 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, randomized controlled trial evaluating the comparative efficacy of written, video, and combined written and video patient education materials relative to no supplemental education for University of California, San Francisco (UCSF) patients presenting for post-mastectomy breast reconstruction consultation.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 or older * Presenting as a new patient to the UCSF plastic surgery breast reconstruction clinic * Considering mastectomy, including: * \- Therapeutic mastectomy in the setting of a breast cancer diagnosis * \- Prophylactic mastectomy in the setting of a confirmed high-risk genetic variant * \- Staged procedures, including delayed mastectomy with initial reduction * Participants who are undecided between lumpectomy and mastectomy Exclusion Criteria: * Established patients returning for follow-up, in order to minimize confounding variables of individual surgeon education style on outcome measures * Participants who are primarily considering lumpectomy or oncoplastic reduction at the time of their visit * Non-English speakers, as educational materials are currently available in English only
Contact & Investigator
Merisa Piper, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07602374 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07602374 currently recruiting?
Yes, NCT07602374 is actively recruiting participants. Contact the research team at Reta.Behman@ucsf.edu for enrollment information.
Where is the NCT07602374 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07602374 clinical trial?
NCT07602374 is sponsored by University of California, San Francisco. The principal investigator is Merisa Piper, MD at University of California, San Francisco. The trial plans to enroll 100 participants.